A recent British Journal of Cancer study investigated how cancer stem cells (CSCs) induce resistance to chimeric antigen receptor T (CAR-T) cell therapy. Furthermore, the effect of Interleukin-24 ...
Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial Autologous MART1-specific CTLs were ...
Gene therapy represents an innovative approach to treating cancer by directly modifying the genetic material within tumour cells, thereby utilising molecular mechanisms to inhibit tumour growth or ...
Interleukin-15 (IL-15) is often considered a central regulator of memory CD8⁺ T cells, based primarily on studies of recirculating subsets. However, recent work identified IL-15–independent CD8⁺ T ...
Acute kidney injury (AKI) is a severe renal disorder affecting approximately 10%–15% of hospitalized patients and up to 50% in intensive care units (ICUs). Its pathogenesis involves complex ...
CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...